Summary by Moomoo AI
Clover Biopharmaceuticals Limited (the “Company”) announced on 23 February 2024 that it will adopt an electronic publication in accordance with Section 2.07A of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited and in compliance with the paperless listing mechanism and the electronic publication company communication requirements effective on 31 December 2023 JSC Communications. The Company's communications include Directors' Reports, Annual Accounts, Audit Reports, Interim Reports, Notice of Meeting, Listing Documents, Circulars and Appointment Forms, etc. The Company informs non-registered shareholders that the English and Chinese versions of all future corporate communications will be available in electronic form on the Company's website and on the easily disclosed website, replacing the printed copies. Non-registered shareholders should proactively check...Show More